Draper hosts first MassMEDIC Women in MedTech Networking and Leadership Forum Event of 2019

CAMBRIDGE, MA—As technology continues to drive the pace of progress in biomedical devices and precision medicine, the traditional line between engineering and medical science grows ever thinner. And as medical machines and the computers that power them become smaller, faster and smarter, the medical device industry is making medical practice easier for doctors, more effective for patients and more cost-effective for the entire healthcare system.

For a sense of how these trends are manifesting themselves today, Draper will sponsor and host the MassMEDIC Women in MedTech Networking and Leadership Forum, 9 to 11 a.m., Feb. 26, at One Hampshire St., Cambridge, MA. The event will feature guest speaker Mary Anne Heino, president and chief executive officer, Lantheus Medical Imaging, Inc.

Tara Clark, vice president of commercial business at Draper, remarked, “Draper celebrates innovation in biomedical technologies and invites the community to join us. We work in interesting times, when breakthrough capabilities are setting a new pace and effectiveness for medical innovation for pharma, healthcare and medical device partners.”

Brian Johnson, president of MassMEDIC, added, “This year’s first MassMEDIC Women in MedTech Networking and Leadership Forum with Draper is the launch of a focused initiative to provide events and programs that address the critical issues and opportunities for the region’s MedTech ecosystem. The MassMEDIC Women in MedTech Forum is designed to inspire, engage, mentor and connect women at every stage of their professional career and from all areas of the New England medtech ecosystem. We are delighted to be working with Draper and all of our sponsors on this event.”

The event will provide attendees an opportunity to network with each other and engage Draper engineers regarding eight biomedical technologies—technologies that are designed to improve lives, change industries and push the boundaries of what is possible.

Anthony Coston, head of medical devices at Draper and a MassMEDIC board member, commented, “The biomedical world is shifting, and the emphasis is on an applied research and product development model that gets devices and therapies to patients, clinicians and biopharma companies sooner. Draper is uniquely positioned to enable the medical tech community to do just that.”

Draper’s showcase of biomedical technologies, each being presented by female engineers and scientists leading these projects, include the following:

Released February 20, 2019

Draper will showcase eight biomedical technologies, each presented by female engineers and scientists leading these projects, when it hosts the first MassMEDIC Women in MedTech Networking and Leadership Forum of 2019.
Concept design of Draper's end-to-end cell bioprocessing system for precision medicine.
Draper is designing an end-to-end cell bioprocessing system, a new addition in the company’s precision medicine portfolio. Shown here is a concept design.
Prototype of Draper's ultrasound technology for early detection of high-risk pregnancies.
Draper has developed an initial concept for an ultrasound technology to enable early detection of high-risk pregnancies in low-resource environments. Shown here is a design prototype.
Rendering of Draper's light field projector module, shown with a coin.
Draper is reinventing the technologies behind 3D displays so that images are sharper and have more depth, a benefit to potential viewers, including soldiers, doctors and moviegoers. Shown here is a rendering.
Close-up of a pediatric heart valve, held by a gloved hand.
Draper has developed and tested a pediatric heart valve that adapts to a child’s growth, the first of its kind.
Draper’s SysteMD™ prototype for psychophysiological-based mental health indicators.
Draper’s SysteMD™ is psychophysiological-based system designed to provide objective, quantitative indicators of mental health. Shown here is a design prototype.
Draper will showcase eight biomedical technologies, each presented by female engineers and scientists leading these projects, when it hosts the first MassMEDIC Women in MedTech Networking and Leadership Forum of 2019.
Draper will showcase eight biomedical technologies, each presented by female engineers and scientists leading these projects, when it hosts the first MassMEDIC Women in MedTech Networking and Leadership Forum of 2019.
Draper is designing an end-to-end cell bioprocessing system, a new addition in the company’s precision medicine portfolio. Shown here is a concept design.
Draper is designing an end-to-end cell bioprocessing system, a new addition in the company’s precision medicine portfolio. Shown here is a concept design.
Draper has developed an initial concept for an ultrasound technology to enable early detection of high-risk pregnancies in low-resource environments. Shown here is a design prototype.
Draper has developed an initial concept for an ultrasound technology to enable early detection of high-risk pregnancies in low-resource environments. Shown here is a design prototype.
Draper is reinventing the technologies behind 3D displays so that images are sharper and have more depth, a benefit to potential viewers, including soldiers, doctors and moviegoers. Shown here is a rendering.
Draper is reinventing the technologies behind 3D displays so that images are sharper and have more depth, a benefit to potential viewers, including soldiers, doctors and moviegoers. Shown here is a rendering.
Draper has developed and tested a pediatric heart valve that adapts to a child’s growth, the first of its kind.
Draper has developed and tested a pediatric heart valve that adapts to a child’s growth, the first of its kind.
Draper’s SysteMD™ is psychophysiological-based system designed to provide objective, quantitative indicators of mental health. Shown here is a design prototype.
Draper’s SysteMD™ is psychophysiological-based system designed to provide objective, quantitative indicators of mental health. Shown here is a design prototype.